The Chartered Institute of Personnel and Development (CIPD) report highlights the negative experiences women face at work due to menstrual symptoms.
Why it matters
The report sheds light on the impact of menstrual symptoms on women's work lives and calls for action to address the stigma and provide support in workplaces.
What the papers say
The Independent says that the study found that four-fifths of women who experienced difficult symptoms had worked when they were too unwell to do so, while The Guardian highlights that women with health conditions such as polycystic ovary syndrome, premenstrual dysphoric disorder (PMDD), or endometriosis faced even greater challenges at work. The Times emphasizes the need for better support for menopausal women, highlighting the inadequate current support and the taboo surrounding hormonal health. The Guardian also reports on new guidelines from the National Institute for Health and Care Excellence (Nice) recommending cognitive behavioral therapy (CBT) as a treatment option for menopause symptoms alongside or instead of hormone replacement therapy (HRT). The Independent and The Times also cover the Nice guidelines, with The Independent noting that women should be offered talking therapy on the NHS to combat menopause symptoms.
How we got here
The report builds on previous discussions around menstrual health and menopause support in the workplace, highlighting the need for better understanding, support, and training for managers.
More on these topics
Hormone replacement therapy, also known as menopausal hormone therapy or postmenopausal hormone therapy, is a form of hormone therapy used to treat symptoms associated with female menopause.
The National Institute for Health and Care Excellence is an executive non-departmental public body of the Department of Health in England, which publishes guidelines in four areas: